openPR Logo
Press release

Ankylosing Spondylitis Drugs Market is Growing in Huge Demand from 2020 to 2027 | Merck & Co., Boehringer Ingelheim, UCB, Amgen and more

03-18-2020 10:31 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Reports And Data

Ankylosing Spondylitis Drugs Market

Ankylosing Spondylitis Drugs Market

Market Size - USD 5.60 Billion in 2018, Market Growth - CAGR of 5.1%, Market Trends - The rising demand for Ankylosing Spondylitis Drugs in developing regions

The global ankylosing spondylitis drugs market is forecast to reach USD 8.82 Billion by 2027, according to a new report by Reports and Data. Ankylosing spondylitis (AS) is a chronic condition that has no permanent cure. It can be defined as an inflammatory disease that results in some of the small bones in the spine (vertebrae) to fuse over time. The fusing of the small bones results in making the spine less flexible and can haunch it in a forward position. In case it affects the rib cage, the patient can have an issue with breathing deeply.

Here, you can avail sample PDF pages and 30 mins free consultation: https://www.reportsanddata.com/sample-enquiry-form/2427

Key participants include Merck & Co., Boehringer Ingelheim, UCB, Amgen, Janssen Biotech, Inc., Johnson & Johnson, Abbvie, Hetero, Zydus Cadila, and Izana Bioscience.

For the purpose of this report, Reports and Data have segmented the global Ankylosing Spondylitis Drugs market, according to Drug Type, Route of Administration, Distribution Channel, Application and Region:

Drug Type Outlook (Revenue, USD Billion; 2016-2027)
Nonsteroidal Anti-Inflammatory Drugs
Anti-Inflammatory Drugs
Immunosuppressive Drugs
TNF blockers
JAK Inhibitors
Steroids
Biologics
Others

Route of Administration Outlook (Revenue, USD Billion; 2016-2027)
Parenteral
Oral

Distribution Channel Outlook (Revenue, USD Billion; 2016-2027)
Hospitals Pharmacy
Retail Pharmacy
Online Pharmacy

Application Outlook (Revenue, USD Billion; 2016-2027)
Adults
Juveniles

Regional Outlook (Revenue, USD Billion; 2016-2027)
North America
Europe
Asia Pacific
MEA
Latin America

Avail this report at Attractive Discount rates! Click here to know more @ https://www.reportsanddata.com/discount-enquiry-form/2427

The condition effects more men as compared to women. Symptoms and signs associated with condition usually initiates in adulthood. Inflammation associated with the condition may also occur in other parts of the body like eyes. Early signs associated with condition may include stiffness and pain in the lower back and hips, particularly in the morning and after prolonged sitting. Fatigue and neck pain are also common in AS. Though there is no cure to the condition with effective medication and treatment, the symptom can be managed and controlled. Various types of medications may help in stopping or delaying spinal problems and ease the pain & swelling. In regards to region, Europe, can be seen to occupy a prominent market share. The market position held by the region is attributed to high prevalence rate of the condition in this region, along with continuously expanding healthcare sector.

Further key findings from the report suggest

The Ankylosing Spondylitis Drugs market held a market value of USD 5.60 Billion in the year 2018 that is forecasted to grow at a rate of 5.1% during the forecast period.

In context to Distribution Channel, the Online Pharmacy segment is projected to witness the fastest growth rate of 5.8% during the forecast period, which is expected to occupy 26.5% by 2027. The growth of online medicine shops, rising trend of online purchase of medicine due to benefits like comfort, convenience, and various offers in these shops contributes to the growth rate witnessed by this segment.

In regards to Application, the Adults segment generated a higher revenue of USD 4.09 Billion in 2018, with a CAGR of 5.5% during the forecast period. The fact that the signs associated with the condition usually initiates in adulthood and appears prior to the age of 45 results in higher application of these medications among adults.

In context to Drug Type, the Nonsteroidal Anti-Inflammatory Drugs segment generated the highest revenue of USD 2.58 Billion in 2018, with a CAGR of 5.3% during the forecast period. Its effectiveness in minimizing inflammation, which is a major impact of the diseases and the main goal of the care services, results in a high demand for Nonsteroidal Anti-Inflammatory Drugs among care providers that contributes to the revenue generated by this segment.

In context to Route of Administration, the Parenteral segment is projected to witness a faster growth rate of 4.3% during the forecast period, which is expected to occupy 35.0% of the market by 2027. The growth rate witnessed by the segment is attributed to the presence of strong pipeline products and continuous development in biologics that are needed to be administered in this way. The fact that medications, when administered in the form of injectable, works the specific problem area and given prompt result, have resulted in its growing popularity care providers.

In regards to the region, Asia Pacific is projected to witness the fastest growth rate of 5.7% during the forecast, which is expected to hold 0% of the market by 2027. The growth rate witnessed by the region is resultant of the expansion of the health care sector, and increasing focus on R&D activities, which is supporting the market growth in this region.

Get the Entire Market Intelligence Report At @ https://www.reportsanddata.com/report-detail/ankylosing-spondylitis-drugs-market

Major highlights of the report:
An all-inclusive evaluation of the parent market
The evolution of significant market aspects
Industry-wide investigation of market segments
Assessment of the market value and volume in the past, present and forecast years
Market share evaluation
Study of niche industrial sectors
Tactical approaches of the market leaders
Lucrative strategies to help companies strengthen their position in the market

Contact Us:
Reports And Data
40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ankylosing Spondylitis Drugs Market is Growing in Huge Demand from 2020 to 2027 | Merck & Co., Boehringer Ingelheim, UCB, Amgen and more here

News-ID: 1973004 • Views:

More Releases from Reports And Data

Point Of Sale (POS) Software Market Insights into the Evolving Landscape of 2032
Point Of Sale (POS) Software Market Insights into the Evolving Landscape of 2032
The latest report by Reports and Data on the global Point Of Sale (POS) Software Market. The report highlights the growing demand for APPLICATION POS software due to the increasing popularity of digital payment solutions and the shift towards cashless purchases accelerated by the COVID-19 pandemic. APPLICATION POS software enables secure and efficient transactions, making it highly sought-after by businesses and customers alike. In addition to facilitating transactions, APPLICATION POS software
Radio Persistence Coaxial Connector (RPC) Market Connecting the World A Look into the Booming 2032
Radio Persistence Coaxial Connector (RPC) Market Connecting the World A Look int …
The Global Radio Persistence Coaxial Connector (RPC) market The increasing demand for wireless communication systems and expanding usage of RPCs across various industries such as telecommunications, aerospace, defense, medical, and automotive, is driving the growth of the market. RPCs are widely used in communication devices, antennas, and other electronic equipment that require high-speed data transfer and dependable connectivity. The projected revenue CAGR of 7.2% during the forecast period indicates a positive
Point Of Sale (POS) Software Market Segmentation and Growth Opportunities in Retail Industry Transformation 2032
Point Of Sale (POS) Software Market Segmentation and Growth Opportunities in Ret …
The latest report by Reports and Data on the global Point Of Sale (POS) Software Market. The report highlights the growing demand for APPLICATION POS software due to the increasing popularity of digital payment solutions and the shift towards cashless purchases accelerated by the COVID-19 pandemic. APPLICATION POS software enables secure and efficient transactions, making it highly sought-after by businesses and customers alike. In addition to facilitating transactions, APPLICATION POS software
Drone Analytics Market The Growing Importance of Drone Analytics in Agriculture 2032
Drone Analytics Market The Growing Importance of Drone Analytics in Agriculture …
  Demand for actionable insights from drone data is driving market revenue growth in a range of industries, including agriculture, construction, mining, and oil & gas. Drones have increased in popularity in recent years due to their ability to capture massive volumes of data more rapidly and inexpensively than traditional methods. The global drone analytics market size was USD 3.93 Billion in 2022 and is expected to register a revenue CAGR of 31% over

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug